Supreme Court’s Medtronic reversal will embolden licensees
The Supreme Court’s unanimous overturning of the Federal Court decision in Medtronic v Mirowski Family Ventures will remove uncertainty over which party has the burden of proof in patent licensing disputes and may lead to further challenges to licensed patents from licensees
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
